Repository logo
 

The AAA+ protein ATAD3 has displacement loop binding properties and is involved in mitochondrial nucleoid organization.

Published version
Peer-reviewed

Change log

Authors

He, J 
Mao, C-C 
Reyes, A 
Sembongi, H 
Di Re, M 

Abstract

Many copies of mammalian mitochondrial DNA contain a short triple-stranded region, or displacement loop (D-loop), in the major noncoding region. In the 35 years since their discovery, no function has been assigned to mitochondrial D-loops. We purified mitochondrial nucleoprotein complexes from rat liver and identified a previously uncharacterized protein, ATAD3p. Localization studies suggested that human ATAD3 is a component of many, but not all, mitochondrial nucleoids. Gene silencing of ATAD3 by RNA interference altered the structure of mitochondrial nucleoids and led to the dissociation of mitochondrial DNA fragments held together by protein, specifically, ones containing the D-loop region. In vitro, a recombinant fragment of ATAD3p bound to supercoiled DNA molecules that contained a synthetic D-loop, with a marked preference over partially relaxed molecules with a D-loop or supercoiled DNA circles. These results suggest that mitochondrial D-loops serve to recruit ATAD3p for the purpose of forming or segregating mitochondrial nucleoids.

Description

Keywords

Adenosine Triphosphatases, Adenosine Triphosphate, Animals, Binding Sites, Binding, Competitive, Cell Line, Tumor, DNA, Mitochondrial, DNA, Single-Stranded, DNA, Superhelical, DNA-Binding Proteins, Electrophoresis, Gel, Two-Dimensional, Electrophoretic Mobility Shift Assay, Humans, Membrane Proteins, Mitochondria, Liver, Mitochondrial Proteins, Nucleic Acid Conformation, Nucleoproteins, Peptide Fragments, Plasmids, Protein Binding, RNA, Small Interfering, Rats, Submitochondrial Particles

Journal Title

Journal of Cell Biology

Conference Name

Journal ISSN

0021-9525
0021-9525

Volume Title

176

Publisher

Rockefeller University Press
Sponsorship
Medical Research Council (MC_U105674181)
Medical Research Council (MC_U105663148)
The study was funded by the UK Medical Research Council, the European Union MitoCombat Integrated Programme (FP6), and a grant from Chang Gung Memorial Hospital, Taiwan (CMRP 1331), to Chih-Chieh (Chris) Mao. Johannes Spelbrink is a member of the FinMIT centre of excellence and is supported by the Academy of Finland, Sigfrid Juselius Foundation, and Tampere University Hospital Medical Research Fund.